Brief: CytRx announces the presentation of its phase 2b clinical trial design in small cell lung cancer
03/09/2015 14:00
Sept 3 (Reuters) - CytRx Corp CYTR.O : * Announces the presentation of its phase 2b clinical trial design in small cell lung cancer at the world conference on lung cancer in Denver, Colorado * Source text for Eikon ID:nPn5y4w2N * Further company coverage CYTR.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on LadRx
See all newsBrief: Ladrx Issues 2024 Update To Shareholders
Brief: LadRx Completes Non-Dilutive Financing Transaction For Up To $11 Mln With Xoma Corporation
Brief: LadRx Intends To Apply To List Stock On Nasdaq Under Symbol 'LADX'
Brief: LadRx Announces Review Of Strategic Alternatives, Provides Corporate Updates
Brief: CytRx Highlights Orphazyme's Update On Productive Meeting With FDA Regarding Arimoclomol In Niemann-Pick Disease Type C